Form 4: Centessa Pharmaceuticals CEO Sells Shares to Cover Tax Obligations

Centessa Pharmaceuticals CEO, Saurabh Saha, sold 36,263 ordinary shares to cover tax obligations related to vesting restricted share units.

Summary

• Centessa Pharmaceuticals CEO, Saurabh Saha, sold 36,263 ordinary shares on December 31, 2024.
• The sale was executed at a price of $16.35 per share.
• This transaction was to cover tax withholding obligations related to the vesting of restricted share units.
• Following the transaction, Mr. Saha directly owns 484,398 ordinary shares.
• He also indirectly owns 38,000 ordinary shares held in a trust.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the pharmaceutical industry.
• Many companies use restricted stock units as part of their executive compensation packages, leading to similar tax-related sales.
• The number of shares sold and the price are within the typical range for such transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Centessa Pharmaceuticals, Saurabh Saha, share sale, tax obligations, restricted share units, insider trading, executive compensation